Product Information
EUTHYROX 150 MCG TABLET is a brand product labeled by Provell Pharmaceuticals, LLC, priced at $0.1880 per EA under NDC 72305015030. Its NADAC has been published 51 times since Jul 17, 2024.
FDA first approved this application on May 31, 2002.
Strength
150 ug/1
Manufacturer
Provell Pharmaceuticals, LLCNDC
72305015030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021292FDA Approved
5/31/2002
On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for EUTHYROX 150 MCG TABLET has been published 51 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1880 per EA |
|---|---|
| All-time high | $0.1894 (Nov 13, 2024) |
| All-time low | $0.1821 (Apr 23, 2025) |
| Median price | $0.1843 |
| Average price | $0.1857 |
| Largest weekly change | -2.7% (Dec 18, 2024) |
| Weeks tracked | 51 |
| Tracking since | Jul 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+0.6%
Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Provell Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levothyroxine sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Thyroxine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EUTHYROX 150 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EUTHYROX 150 MCG TABLET, manufactured by Provell Pharmaceuticals, LLC, is $0.1880 per EA (NDC 72305015030), effective Jul 2, 2025.
How has the price of EUTHYROX 150 MCG TABLET changed over time?
Over the history we have for it, the NADAC for EUTHYROX 150 MCG TABLET has held within roughly two percent of its current level. It has been tracked across 51 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for EUTHYROX 150 MCG TABLET?
Since Jul 17, 2024, the NADAC for EUTHYROX 150 MCG TABLET has ranged from a low of $0.1821 (Apr 23, 2025) to a high of $0.1894 (Nov 13, 2024), with a median of $0.1843 per EA.
Are there cheaper alternatives to EUTHYROX 150 MCG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOTHYROXINE 150 MCG TABLET, is $0.0586 per EA — about 69% below EUTHYROX 150 MCG TABLET.
Who manufactures EUTHYROX 150 MCG TABLET?
EUTHYROX 150 MCG TABLET (NDC 72305015030) is labeled by Provell Pharmaceuticals, LLC, and CMS classifies it as a brand product.